 |
 |

Continuing Medical Education, Physicians, and PavlovCan We Change What Happens When Industry Rings the Bell?
Paul R. Lichter, MD
Arch Ophthalmol. 2008;126(11):1593-1597.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
"The traditional independence of physicians and the welfare of the public are being threatened by the new vogue among drug manufacturers to promote their products by assuming an aggressive role in the education of doctors."1 Although written nearly half a century ago, this comment is worth considering today, especially as it pertains to continuing medical education (CME).
We commonly invoke CME to mean something good and something needed. In many ways, we seem to respond to it with a conditioned, Pavlovian response. Continuing medical education helps assure us and our patients that we are up to date in a fast-changing medical environment. The number of CME offerings grows annually. Yet, while it grows, much has transpired in the CME field to turn it on its head. Physician-industry relationships in CME have led to a creeping skepticism about how CME is planned and financed. Questions are being . . . [Full Text of this Article] CME'S BEGINNINGS
EVOLUTION OF THE CME INDUSTRY
CME ACCREDITATION AND MANDATES
WHO PAYS FOR CME?
INDUSTRY ADAPTS ITS GIFT-GIVING APPROACH
THE EXPANSION OF CME AND INDUSTRY'S INVOLVEMENT
MEDICAL EDUCATION SERVICE SUPPLIERS
STOKING PHYSICIANS CME INSTINCTS
WHAT CAN BE DONE?
CHANGING THE PICTURE
EXAMPLE OF A VIRTUOUS ORGANIZATION
CONCLUSIONS
AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
A Perspective on Commercial Relationships Between Ophthalmology and Industry
Jampol et al.
Arch Ophthalmol 2009;127:1194-1202.
ABSTRACT
| FULL TEXT
|